In this on-demand webcast, an expert discusses how to identify and manage antibody drug conjugate (ADC)-related adverse events following treatment with those directed at HER2, HER3, and TROP2.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://clinicaloptions.com/activities/oncology/adc-related-aes/64822/info
- Start Date: 2024-12-04 06:00:00
- End Date: 2024-12-04 06:00:00
- Credit Details: IPCE Credits: 0.75 hours
AAPA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours - Commercial Support: Source: AstraZeneca (Any division) - Amount: 31250.0 - Is Kind Support: False Source: Gilead Sciences, Inc. - Amount: 31250.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest